1. Home
  2. EPIX vs BRID Comparison

EPIX vs BRID Comparison

Compare EPIX & BRID Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EPIX
  • BRID
  • Stock Information
  • Founded
  • EPIX 2009
  • BRID 1932
  • Country
  • EPIX Canada
  • BRID United States
  • Employees
  • EPIX N/A
  • BRID N/A
  • Industry
  • EPIX Biotechnology: Pharmaceutical Preparations
  • BRID Specialty Foods
  • Sector
  • EPIX Health Care
  • BRID Consumer Staples
  • Exchange
  • EPIX Nasdaq
  • BRID Nasdaq
  • Market Cap
  • EPIX 75.9M
  • BRID 70.3M
  • IPO Year
  • EPIX N/A
  • BRID N/A
  • Fundamental
  • Price
  • EPIX $1.72
  • BRID $7.65
  • Analyst Decision
  • EPIX Hold
  • BRID
  • Analyst Count
  • EPIX 3
  • BRID 0
  • Target Price
  • EPIX $2.00
  • BRID N/A
  • AVG Volume (30 Days)
  • EPIX 68.7K
  • BRID 1.9K
  • Earning Date
  • EPIX 08-04-2025
  • BRID 06-02-2025
  • Dividend Yield
  • EPIX N/A
  • BRID N/A
  • EPS Growth
  • EPIX N/A
  • BRID N/A
  • EPS
  • EPIX N/A
  • BRID N/A
  • Revenue
  • EPIX N/A
  • BRID $224,673,000.00
  • Revenue This Year
  • EPIX N/A
  • BRID N/A
  • Revenue Next Year
  • EPIX N/A
  • BRID N/A
  • P/E Ratio
  • EPIX N/A
  • BRID N/A
  • Revenue Growth
  • EPIX N/A
  • BRID N/A
  • 52 Week Low
  • EPIX $1.40
  • BRID $7.52
  • 52 Week High
  • EPIX $7.88
  • BRID $14.69
  • Technical
  • Relative Strength Index (RSI)
  • EPIX 55.34
  • BRID 40.57
  • Support Level
  • EPIX $1.60
  • BRID $7.64
  • Resistance Level
  • EPIX $1.73
  • BRID $7.88
  • Average True Range (ATR)
  • EPIX 0.04
  • BRID 0.17
  • MACD
  • EPIX 0.00
  • BRID -0.01
  • Stochastic Oscillator
  • EPIX 76.50
  • BRID 6.38

About EPIX ESSA Pharma Inc.

ESSA Pharma Inc is a pharmaceutical company. The company was focused on the development of small-molecule drugs for the treatment of castration-resistant prostate cancer. It was developing drugs that selectively block the amino-terminal domain of the androgen receptor, potentially overcoming the known AR-dependent resistance mechanisms of CRPC and providing CRPC patients with the potential for increased progression-free and overall survival. Currently, the company has terminated its clinical trials and other studies.

About BRID Bridgford Foods Corporation

Bridgford Foods Corp manufactures, markets, and distributes frozen and snack food products in the United States. The business segments are; the processing and distribution of frozen products, and the processing and distribution of snack food products. Its product offerings include meat snacks, breads and rolls, biscuits, and ready-to-eat sandwiches among others. The company offers frozen food products to the foodservice and retail customers through wholesalers, cooperatives, and distributors; and snack food items to supermarkets, and mass merchandise and convenience retail stores through customer-owned distribution centers, as well as a direct store delivery network. A majority of the company's revenue is derived from the snack food products segment.

Share on Social Networks: